REV-ERBα agonist SR10067 attenuates Th2 cytokine-mediated barrier dysfunction in human bronchial epithelial cells is a research paper published in Clinical Science (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of Kansas Medical Center, School of Medicine,
Grant: Internal Medicine Start-up funds
National Heart, Lung, and Blood Institute
Grant: R01 HL142543
MeSH Terms
Keywords